Pinned Tweet
M. Javad Aman, Ph.D., President, and CEO of Integrated BioTherapeutics, discusses his Montgomery County-based company's R&D mission to develop vaccines and therapies to combat emerging infectious diseases.
For full video visit: ibtbioservices.com/
"Here we report the development of pan-ebolavirus and pan-filovirus antibodies generated by repeated immunization of mice with filovirus glycoproteins engineered to drive the B cell responses toward conserved epitopes."
pubmed.ncbi.nlm.nih.gov/2646…
"The severe death toll caused by the recent outbreak of Ebola virus disease reinforces the importance of developing ebolavirus prevention and treatment strategies."
#researchanddevelopment #vaccinedevelopment #biotechnology #vaccine #ebola #prevention
integratedbiotherapeutics.co…
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques
#researchanddevelopment #research #vaccinedevelopment #biotechnology #VaccineRollOutSA
integratedbiotherapeutics.co…
Check this out!
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus
#researchanddevelopment #research #vaccinedevelopment #biotechnology #vaccine
integratedbiotherapeutics.co…
Check out our publication: Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
integratedbiotherapeutics.co…
IBT works diligently to help control infectious diseases through our antiviral and antibacterial research programs.
#antiviral #antibacterial #pipeline #infectiousdiseases
Take a look at our technology platforms and pipelines: integratedbiotherapeutics.co…
What can the history of antimicrobial resistance tell us about future pandemics?
#publicheath #antimicrobials #antimicrobialresistance #researchanddevelopment
lnkd.in/gCbft3f
Our team has extensive experience in molecular and enzymatic assays, and immunoassays as single- and multiplexed platforms. Visit the IBT Bioservices website to learn more.
#flowcytometry #assaydevelopment #proteinpurification
lnkd.in/dRhk5HJ
IBT Receives Phase I SBIR grant from NIAID for development of Novel ISTAb therapeutics for Staph aureus #NIH #grant #development #therapeutics
Full view here: integratedbiotherapeutics.co…
Integrated Biotherapeutics retweeted
Let’s come together this June to celebrate the progress that has been made to promote health equity for the LGBTQ+ community and reflect on the work ahead. hhs.gov/about/news/2021/05/1… #Pride #PrideMonth
IBT Receives Phase I/II Fast Track SBIR grant from NIAID for development of broadly protective monoclonal antibodies against Influenza Virus (INFV) #NIAID #development #influenza #virus
Read the full story:
integratedbiotherapeutics.co…
IBT Receives Phase I SBIR grant from NIAID for development of neutralizing monoclonal antibodies against Marburg Virus #development #marburg #grant #NIAID
Full read here: integratedbiotherapeutics.co…
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
Read more here: integratedbiotherapeutics.co…
CARB-X funds Integrated BioTherapeutics to expand the development of its staphylococcus aureus vaccine to facilitate use in the developing world #vaccine #research #development #innovative
Read more here: integratedbiotherapeutics.co…
Novo Holdings REPAIR Impact Fund Invests USD 12 million in Mutabilis and IBT Vaccines and provides a strategic update!
View the full article here: integratedbiotherapeutics.co…
Recent clinical successes of monoclonal antibodies (mAbs) in therapy for viral infections demonstrate that mAbs offer a solution for these emerging biothreats.
#immunotherapy #antibodies #researchanddevelopment
integratedbiotherapeutics.co…









